DCVax clinical trial starts in Germany

|By:, SA News Editor

Northwest Biotherapeutics (NWBO) initiates a DCVax Phase 3 clinical trial at a medical center in Dresden, Germany. Three more sites will come on line in June followed by four more in July. The Dresden site has begun screening patients for enrollment. The initiation process will take ~six months per site according to the company.